DESMOPRESSIN ACETATE

DESMOPRESSIN ACETATE was reported 3816 times

DESMOPRESSIN ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OUT OF SPECIFICATION PRODUCT USE 56 0.6512
1 CNS GERMINOMA 4 0.2500
2 MECHANICAL VENTILATION COMPLICATION 25 0.1678
3 CRANIOPHARYNGIOMA 36 0.1084
4 INSPIRATORY CAPACITY DECREASED 27 0.0975
5 PUNCTURE SITE HAEMATOMA 6 0.0938
6 HYPONATRAEMIC ENCEPHALOPATHY 14 0.0693
7 GERM CELL CANCER 10 0.0690
8 HYPONATRAEMIC SEIZURE 16 0.0630
9 WATER INTOXICATION 30 0.0593
10 LABELLED DRUG-DISEASE INTERACTION MEDICATION ERROR 29 0.0497
11 HYPERCORTICOIDISM 4 0.0377
12 SPECIFIC GRAVITY URINE ABNORMAL 3 0.0353
13 MYOCARDIAL CALCIFICATION 3 0.0256
14 EPIPHYSIOLYSIS 6 0.0241
15 ASTROCYTOMA, LOW GRADE 4 0.0235
16 INSULIN-LIKE GROWTH FACTOR DECREASED 12 0.0227
17 ADMINISTRATION SITE HAEMORRHAGE 2 0.0192
18 OSMOTIC DEMYELINATION SYNDROME 14 0.0190
19 DIABETES INSIPIDUS 45 0.0187
20 PLATELET DYSFUNCTION 5 0.0180
21 PITUITARY TUMOUR RECURRENT 3 0.0172
22 BUDD-CHIARI SYNDROME 4 0.0158
23 MELANODERMA 3 0.0156
24 URINE SODIUM INCREASED 3 0.0142
25 SHUNT MALFUNCTION 4 0.0141
26 BLADDER DIVERTICULUM 2 0.0127
27 ASTROCYTOMA 5 0.0127
28 BLOOD OSMOLARITY INCREASED 4 0.0122
29 INSULIN-LIKE GROWTH FACTOR INCREASED 17 0.0119
30 HYPOPITUITARISM 20 0.0115
31 ACANTHOSIS NIGRICANS 2 0.0108
32 BLOOD SODIUM ABNORMAL 11 0.0103
33 DROP ATTACKS 6 0.0101
34 HAEMOTHORAX 29 0.0100
35 PUNCTURE SITE HAEMORRHAGE 7 0.0099
36 BLOOD SODIUM INCREASED 26 0.0096
37 BACTERIAL TRANSLOCATION 3 0.0095
38 HYPERNATRAEMIA 46 0.0092
39 TONSILLAR DISORDER 10 0.0089
40 RECALLED PRODUCT ADMINISTERED 83 0.0087
41 COGWHEEL RIGIDITY 9 0.0086
42 DYSPLASTIC NAEVUS 3 0.0083
43 ALBUMIN URINE PRESENT 3 0.0079
44 INTRACRANIAL TUMOUR HAEMORRHAGE 3 0.0078
45 NEOPLASM RECURRENCE 25 0.0074
46 PHARYNGEAL HAEMORRHAGE 9 0.0073
47 BLOOD GROWTH HORMONE INCREASED 4 0.0072
48 APNOEIC ATTACK 4 0.0071
49 INTENTION TREMOR 4 0.0070
50 ANTICHOLINERGIC SYNDROME 11 0.0069
51 SEXUALLY TRANSMITTED DISEASE 3 0.0069
52 GASTRIC FISTULA 3 0.0067
53 HYPOGLYCAEMIC SEIZURE 6 0.0066
54 HEAD TITUBATION 9 0.0065
55 HAEMORRHAGIC DISORDER 7 0.0064
56 HYPONATRAEMIA 358 0.0063
57 RESTING TREMOR 4 0.0062
58 ARTERIAL HAEMORRHAGE 7 0.0061
59 NEPHROGENIC DIABETES INSIPIDUS 7 0.0061
60 WRONG PATIENT 3 0.0060
61 DIABETES MELLITUS INSULIN-DEPENDENT 3 0.0060
62 BACTERIAL PYELONEPHRITIS 2 0.0060
63 CHORIORETINOPATHY 8 0.0056
64 DRUG EFFECT PROLONGED 3 0.0054
65 HYPOVOLAEMIA 30 0.0051
66 PITTING OEDEMA 3 0.0049
67 THYROXINE DECREASED 3 0.0048
68 BLOOD OSMOLARITY DECREASED 3 0.0048
69 THIRST DECREASED 3 0.0048
70 THYROXINE FREE INCREASED 3 0.0047
71 ANAL SPHINCTER ATONY 2 0.0047
72 ANGIOPATHY 26 0.0046
73 BLOOD SODIUM DECREASED 87 0.0046
74 ADRENOCORTICAL INSUFFICIENCY ACUTE 9 0.0046
75 INFECTIOUS PERITONITIS 3 0.0044
76 SUBILEUS 9 0.0043
77 SEDATION COMPLICATION 11 0.0043
78 PITUITARY TUMOUR BENIGN 7 0.0043
79 SLEEP-RELATED EATING DISORDER 4 0.0043
80 BITE 3 0.0041
81 PITUITARY TUMOUR 6 0.0040
82 ENURESIS 16 0.0040
83 LIMB ASYMMETRY 3 0.0039
84 SHOCK HAEMORRHAGIC 30 0.0037
85 BLOOD CHLORIDE DECREASED 9 0.0035
86 BLOOD CHLORIDE INCREASED 6 0.0035
87 URINE OUTPUT INCREASED 9 0.0034
88 HYPOTHALAMO-PITUITARY DISORDER 5 0.0034
89 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 3 0.0034
90 POLYURIA 26 0.0032
91 POLYDIPSIA 12 0.0030
92 REACTION TO EXCIPIENT 7 0.0030
93 PRINZMETAL ANGINA 3 0.0030
94 VENA CAVA THROMBOSIS 5 0.0030
95 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
96 VASCULAR STENT THROMBOSIS 6 0.0029
97 POSTICTAL STATE 3 0.0029
98 EMPHYSEMA 29 0.0029
99 PUPILLARY REFLEX IMPAIRED 5 0.0027
100 APRAXIA 4 0.0027
101 BENIGN NEOPLASM 3 0.0027
102 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 2 0.0027
103 PRODUCT DELIVERY MECHANISM ISSUE 14 0.0026
104 HYPERTROPHIC CARDIOMYOPATHY 4 0.0026
105 THROMBOTIC THROMBOCYTOPENIC PURPURA 9 0.0026
106 CYSTITIS INTERSTITIAL 4 0.0025
107 PULMONARY ARTERIAL PRESSURE INCREASED 4 0.0025
108 BRAIN INJURY 24 0.0024
109 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
110 OESOPHAGEAL DISORDER 9 0.0023
111 PHYSICAL DECONDITIONING 6 0.0023
112 ELECTROLYTE IMBALANCE 27 0.0023
113 RECALLED PRODUCT 4 0.0023
114 THIRST 41 0.0023
115 ABNORMAL SLEEP-RELATED EVENT 3 0.0023
116 BODY MASS INDEX INCREASED 3 0.0022
117 GRAND MAL CONVULSION 20 0.0022
118 BRAIN OEDEMA 27 0.0021
119 HYPERCOAGULATION 4 0.0021
120 MOUTH SWELLING 12 0.0021
121 LABELLED DRUG-DRUG INTERACTION ISSUE 3 0.0021
122 DIABETES MELLITUS NON-INSULIN-DEPENDENT 3 0.0021
123 MELANOCYTIC NAEVUS 9 0.0021
124 ADVERSE REACTION 27 0.0020
125 EXCESSIVE EYE BLINKING 3 0.0020
126 HYDROCEPHALUS 11 0.0020
127 FACE OEDEMA 34 0.0020
128 MYOCLONIC EPILEPSY 3 0.0020
129 EMBOLISM VENOUS 6 0.0020
130 INTRACARDIAC THROMBUS 6 0.0020
131 GRANULOCYTOPENIA 11 0.0019
132 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
133 URINE KETONE BODY PRESENT 3 0.0019
134 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 19 0.0018
135 PNEUMOTHORAX 29 0.0018
136 CLONUS 5 0.0018
137 THERAPEUTIC PRODUCT EFFECT VARIABLE 7 0.0018
138 TONSILLECTOMY 3 0.0018
139 PRE-EXISTING CONDITION IMPROVED 11 0.0018
140 PHARYNGEAL DISORDER 5 0.0017
141 INCORRECT STORAGE OF DRUG 3 0.0017
142 PRODUCT CONTAINER SEAL ISSUE 3 0.0017
143 EXTRAVASATION 7 0.0017
144 DISTURBANCE IN SOCIAL BEHAVIOUR 4 0.0017
145 NYSTAGMUS 9 0.0017
146 WRONG DOSE 4 0.0017
147 NASAL DISCOMFORT 13 0.0016
148 POOR QUALITY PRODUCT ADMINISTERED 17 0.0016
149 URINE OUTPUT DECREASED 14 0.0016
150 BLOOD CREATININE DECREASED 5 0.0016
151 NARCOLEPSY 3 0.0016
152 URINARY TRACT DISORDER 7 0.0016
153 APGAR SCORE LOW 2 0.0016
154 ARTERIAL THROMBOSIS 3 0.0016
155 BRAIN NEOPLASM 14 0.0015
156 LUNG OPACITY 4 0.0015
157 SUDDEN HEARING LOSS 3 0.0015
158 NOCTURIA 18 0.0015
159 HYPOVOLAEMIC SHOCK 7 0.0015
160 NEUROGENIC BLADDER 3 0.0014
161 SLEEP DEFICIT 3 0.0014
162 RENAL NEOPLASM 3 0.0014
163 CD4 LYMPHOCYTES DECREASED 3 0.0014
164 INTERCEPTED PRODUCT STORAGE ERROR 5 0.0014
165 GROWTH RETARDATION 4 0.0014
166 URINE ANALYSIS ABNORMAL 4 0.0013
167 EPISTAXIS 100 0.0013
168 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
169 CONVULSION 75 0.0013
170 PRE-ECLAMPSIA 6 0.0013
171 FAECAL INCONTINENCE 6 0.0012
172 POLLAKIURIA 51 0.0012
173 SELF-MEDICATION 5 0.0012
174 CARTILAGE INJURY 3 0.0012
175 SPINAL COMPRESSION FRACTURE 10 0.0012
176 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 5 0.0012
177 POTENTIATING DRUG INTERACTION 4 0.0012
178 PLATELET DISORDER 3 0.0012
179 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 6 0.0012
180 DRUG TITRATION ERROR 3 0.0012
181 ANURIA 10 0.0012
182 PRIAPISM 4 0.0012
183 CONTRAINDICATED PRODUCT ADMINISTERED 35 0.0012
184 HEPATITIS TOXIC 3 0.0012
185 PERSONALITY DISORDER 3 0.0011
186 LOGORRHOEA 4 0.0011
187 BLOOD POTASSIUM ABNORMAL 3 0.0011
188 AORTIC VALVE STENOSIS 2 0.0011
189 GASTROINTESTINAL INFECTION 10 0.0011
190 ANAPHYLACTIC SHOCK 28 0.0011
191 COMMUNICATION DISORDER 4 0.0010
192 ADRENAL DISORDER 2 0.0010
193 INCONTINENCE 11 0.0010
194 BLOOD TESTOSTERONE DECREASED 7 0.0010
195 STRABISMUS 3 0.0010
196 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
197 CEREBRAL ATROPHY 4 0.0010
198 HYPERPHAGIA 4 0.0010
199 AZOTAEMIA 4 0.0010
200 METABOLIC ENCEPHALOPATHY 3 0.0010
201 DRUG TOLERANCE 5 0.0010
202 VISUAL FIELD DEFECT 7 0.0010
203 ATRIAL THROMBOSIS 2 0.0010
204 SLEEP TERROR 4 0.0009
205 STUPOR 3 0.0009
206 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
207 DIVERTICULUM INTESTINAL 4 0.0009
208 JAW DISORDER 5 0.0009
209 BLOOD CALCIUM INCREASED 8 0.0009
210 INTESTINAL ISCHAEMIA 5 0.0009
211 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
212 LYME DISEASE 3 0.0009
213 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
214 MULTIPLE ALLERGIES 7 0.0009
215 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
216 PERONEAL NERVE PALSY 5 0.0009
217 HYPERTONIA 5 0.0009
218 MICTURITION DISORDER 3 0.0009
219 PETECHIAE 9 0.0009
220 PERSONALITY CHANGE 8 0.0009
221 URINE ODOUR ABNORMAL 5 0.0008
222 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
223 MUSCLE RIGIDITY 10 0.0008
224 PLATELET COUNT ABNORMAL 5 0.0008
225 HYPERACUSIS 3 0.0008
226 CYST 10 0.0008
227 OLIGURIA 5 0.0008
228 HYPERAMMONAEMIA 4 0.0008
229 STATUS EPILEPTICUS 9 0.0008
230 TOXIC SKIN ERUPTION 8 0.0008
231 PARANASAL SINUS DISCOMFORT 3 0.0008
232 FACE INJURY 3 0.0008
233 APPENDICITIS PERFORATED 2 0.0008
234 PETIT MAL EPILEPSY 4 0.0008
235 WEIGHT LOSS POOR 4 0.0008
236 DRUG PRESCRIBING ERROR 15 0.0008
237 CAESAREAN SECTION 9 0.0008
238 PROCEDURAL HAEMORRHAGE 3 0.0008
239 MALABSORPTION 4 0.0008
240 SOMNAMBULISM 5 0.0008
241 POLYARTHRITIS 4 0.0008
242 GASTROENTERITIS 11 0.0008
243 PHARYNGOLARYNGEAL PAIN 4 0.0008
244 MENINGITIS 5 0.0007
245 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
246 FEAR 20 0.0007
247 BRUXISM 4 0.0007
248 ALTERED STATE OF CONSCIOUSNESS 16 0.0007
249 FLUSHING 75 0.0007
250 TIC 4 0.0007
251 ABNORMAL LOSS OF WEIGHT 5 0.0007
252 GINGIVAL BLEEDING 10 0.0007
253 FAECALOMA 4 0.0007
254 ANHEDONIA 19 0.0007
255 FLATULENCE 41 0.0007
256 URINARY RETENTION 24 0.0007
257 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
258 INTRACRANIAL PRESSURE INCREASED 4 0.0007
259 DEFAECATION URGENCY 5 0.0007
260 RIGHT VENTRICULAR FAILURE 5 0.0007
261 MENORRHAGIA 14 0.0007
262 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
263 FLUID RETENTION 36 0.0007
264 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
265 MICTURITION URGENCY 8 0.0007
266 ANOREXIA 9 0.0007
267 VISUAL DISTURBANCE 4 0.0007
268 NEOPLASM 8 0.0007
269 PSYCHOLOGICAL TRAUMA 6 0.0007
270 MULTI-ORGAN FAILURE 12 0.0007
271 SEIZURE 79 0.0007
272 PARONYCHIA 3 0.0007
273 DISORIENTATION 27 0.0007
274 URINARY INCONTINENCE 20 0.0007
275 ANAPHYLACTIC REACTION 37 0.0007
276 SUDDEN DEATH 7 0.0007
277 LETHARGY 38 0.0007
278 FOETAL GROWTH RESTRICTION 4 0.0007
279 TROPONIN INCREASED 5 0.0007
280 HAEMODYNAMIC INSTABILITY 5 0.0007
281 PRODUCT STORAGE ERROR 57 0.0007
282 EYE OPERATION 3 0.0007
283 COMA 31 0.0007
284 HAEMORRHAGE 68 0.0006
285 IRON DEFICIENCY ANAEMIA 6 0.0006
286 SCOLIOSIS 4 0.0006
287 APNOEA 5 0.0006
288 BLOOD PROLACTIN INCREASED 3 0.0006
289 INFUSION SITE SWELLING 4 0.0006
290 LOW BIRTH WEIGHT BABY 5 0.0006
291 SLEEP APNOEA SYNDROME 12 0.0006
292 KIDNEY TRANSPLANT REJECTION 3 0.0006
293 MUSCLE DISORDER 5 0.0006
294 DEHYDRATION 82 0.0006
295 POLYP 4 0.0006
296 HEPARIN-INDUCED THROMBOCYTOPENIA 3 0.0006
297 BREATH SOUNDS ABNORMAL 3 0.0006
298 HYPERVOLAEMIA 3 0.0006
299 LIGAMENT SPRAIN 6 0.0006
300 GENERALISED TONIC-CLONIC SEIZURE 10 0.0006
301 KLEBSIELLA INFECTION 3 0.0006
302 EPILEPSY 18 0.0006
303 MOTOR DYSFUNCTION 6 0.0006
304 NEUTROPHIL COUNT INCREASED 6 0.0006
305 PRODUCT CONTAINER ISSUE 5 0.0006
306 CEREBRAL ISCHAEMIA 3 0.0006
307 HYPOCALCAEMIA 11 0.0006
308 TRISMUS 3 0.0006
309 ADRENAL INSUFFICIENCY 7 0.0006
310 MIGRAINE 55 0.0006
311 MENTAL STATUS CHANGES 16 0.0006
312 TONSILLITIS 3 0.0006
313 NO THERAPEUTIC RESPONSE 7 0.0006
314 PARTIAL SEIZURES 3 0.0006
315 POST PROCEDURAL COMPLICATION 11 0.0006
316 DYSURIA 21 0.0006
317 HALLUCINATION, VISUAL 12 0.0006
318 RETCHING 12 0.0006
319 APPENDICECTOMY 2 0.0006
320 FOOD POISONING 3 0.0006
321 PLEURAL EFFUSION 34 0.0006
322 HIP SURGERY 3 0.0006
323 CARDIOVASCULAR DISORDER 14 0.0006
324 HYPOPHAGIA 14 0.0005
325 UROSEPSIS 5 0.0005
326 PHARMACEUTICAL PRODUCT COMPLAINT 14 0.0005
327 BLOOD UREA INCREASED 9 0.0005
328 HEPATIC STEATOSIS 10 0.0005
329 SUNBURN 4 0.0005
330 MIDDLE INSOMNIA 10 0.0005
331 FLANK PAIN 5 0.0005
332 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
333 PREMATURE LABOUR 3 0.0005
334 AUTOIMMUNE THYROIDITIS 2 0.0005
335 CARDIAC VALVE DISEASE 3 0.0005
336 ACIDOSIS 4 0.0005
337 SHOCK 12 0.0005
338 BLOOD CREATINE PHOSPHOKINASE INCREASED 15 0.0005
339 ATELECTASIS 5 0.0005
340 CONCUSSION 4 0.0005
341 METASTASES TO LIVER 9 0.0005
342 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
343 ENERGY INCREASED 3 0.0005
344 RENAL INJURY 15 0.0005
345 BLOOD ALBUMIN DECREASED 4 0.0005
346 PRODUCT PRESCRIBING ERROR 12 0.0005
347 OBESITY 8 0.0005
348 RENAL IMPAIRMENT 42 0.0005
349 RESPIRATORY TRACT INFECTION 13 0.0005
350 TYPE 1 DIABETES MELLITUS 3 0.0005
351 DRUG INTERACTION 79 0.0005
352 RHINITIS 4 0.0005
353 TACHYCARDIA 44 0.0005
354 LYMPHOPENIA 7 0.0005
355 PRODUCT ADMINISTRATION ERROR 10 0.0005
356 HYPOTHERMIA 5 0.0005
357 SINUS TACHYCARDIA 7 0.0005
358 TENSION 3 0.0005
359 DELIRIUM 17 0.0005
360 SUBDURAL HAEMATOMA 7 0.0005
361 DRUG EFFECT DECREASED 26 0.0005
362 INFUSION SITE EXTRAVASATION 3 0.0005
363 SWOLLEN TONGUE 15 0.0005
364 DYSARTHRIA 18 0.0005
365 HYPOGLYCAEMIA 23 0.0005
366 BLOOD URINE PRESENT 9 0.0005
367 SCREAMING 3 0.0005
368 PRODUCT SUBSTITUTION ISSUE 27 0.0005
369 SEROTONIN SYNDROME 9 0.0005
370 RESPIRATORY DISORDER 14 0.0005
371 BLOOD POTASSIUM DECREASED 14 0.0005
372 UNRESPONSIVE TO STIMULI 12 0.0005
373 APHASIA 14 0.0005
374 AGGRESSION 23 0.0005
375 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
376 BRADYPHRENIA 3 0.0005
377 ASPIRATION 5 0.0005
378 PRODUCT FORMULATION ISSUE 3 0.0005
379 GASTROINTESTINAL PAIN 5 0.0005
380 PRODUCT COMMUNICATION ISSUE 4 0.0005
381 LYMPHOMA 7 0.0005
382 ANKLE FRACTURE 7 0.0005
383 CONFUSIONAL STATE 73 0.0005
384 WRONG DRUG ADMINISTERED 4 0.0004
385 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
386 POST-TRAUMATIC STRESS DISORDER 3 0.0004
387 MALNUTRITION 5 0.0004
388 HAEMARTHROSIS 4 0.0004
389 METASTASES TO LYMPH NODES 3 0.0004
390 GASTROENTERITIS VIRAL 8 0.0004
391 HEAD INJURY 14 0.0004
392 ACUTE MYOCARDIAL INFARCTION 13 0.0004
393 PSYCHOTIC DISORDER 13 0.0004
394 PRODUCT AVAILABILITY ISSUE 10 0.0004
395 EYE MOVEMENT DISORDER 3 0.0004
396 CHOLECYSTECTOMY 5 0.0004
397 RIB FRACTURE 9 0.0004
398 HEADACHE 274 0.0004
399 SENSORY DISTURBANCE 7 0.0004
400 HUNGER 6 0.0004
401 ABNORMAL BEHAVIOUR 17 0.0004
402 INJURY 30 0.0004
403 BLOOD PRESSURE INCREASED 65 0.0004
404 UNEVALUABLE EVENT 32 0.0004
405 FOOT FRACTURE 8 0.0004
406 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
407 ATAXIA 5 0.0004
408 PRODUCT SUPPLY ISSUE 3 0.0004
409 IRRITABLE BOWEL SYNDROME 9 0.0004
410 CHOLECYSTITIS 5 0.0004
411 DERMATITIS BULLOUS 3 0.0004
412 HEMIPARESIS 7 0.0004
413 CEREBRAL INFARCTION 10 0.0004
414 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
415 FEELING HOT 25 0.0004
416 DRY MOUTH 33 0.0004
417 OEDEMA 22 0.0004
418 HOSPICE CARE 4 0.0004
419 LIMB INJURY 11 0.0004
420 ABASIA 10 0.0004
421 MOOD ALTERED 11 0.0004
422 INABILITY TO AFFORD MEDICATION 4 0.0004
423 ABDOMINAL TENDERNESS 2 0.0004
424 COLON CANCER 6 0.0004
425 TREATMENT NONCOMPLIANCE 22 0.0004
426 THERAPEUTIC RESPONSE UNEXPECTED 18 0.0004
427 HYPOTONIA 4 0.0004
428 HYPOTENSION 80 0.0004
429 HYPOAESTHESIA ORAL 6 0.0004
430 DRUG DISPENSING ERROR 6 0.0004
431 AMMONIA INCREASED 2 0.0004
432 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
433 RENAL FAILURE CHRONIC 3 0.0004
434 HYPOKALAEMIA 18 0.0004
435 SYNCOPE 39 0.0004
436 MYDRIASIS 5 0.0004
437 THYROID DISORDER 6 0.0004
438 HAEMOLYSIS 3 0.0004
439 TEMPERATURE INTOLERANCE 4 0.0004
440 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
441 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
442 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
443 AFFECTIVE DISORDER 3 0.0004
444 GINGIVAL PAIN 3 0.0004
445 NEOPLASM PROGRESSION 13 0.0004
446 HEART RATE INCREASED 37 0.0004
447 MALIGNANT MELANOMA 5 0.0004
448 MENTAL IMPAIRMENT 9 0.0004
449 MUSCLE TIGHTNESS 6 0.0004
450 EXPOSURE DURING PREGNANCY 23 0.0004
451 SKIN LACERATION 4 0.0004
452 ASPHYXIA 3 0.0004
453 ENCEPHALOPATHY 9 0.0004
454 INCREASED APPETITE 7 0.0004
455 MANIA 6 0.0004
456 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
457 URINARY TRACT INFECTION 62 0.0004
458 SOMNOLENCE 73 0.0004
459 MENSTRUAL DISORDER 3 0.0004
460 MEDICATION ERROR 20 0.0004
461 LIVE BIRTH 3 0.0004
462 COORDINATION ABNORMAL 5 0.0004
463 HAEMODIALYSIS 3 0.0004
464 SENSATION OF FOREIGN BODY 3 0.0004
465 INFUSION SITE ERYTHEMA 3 0.0004
466 BLOOD CALCIUM DECREASED 4 0.0004
467 RENAL FAILURE ACUTE 15 0.0004
468 MITRAL VALVE INCOMPETENCE 4 0.0004
469 SEASONAL ALLERGY 5 0.0004
470 SCAB 4 0.0004
471 MYOCARDITIS 4 0.0003
472 NEPHROLITHIASIS 16 0.0003
473 BLOOD MAGNESIUM DECREASED 3 0.0003
474 MUSCLE TWITCHING 8 0.0003
475 PARAESTHESIA ORAL 5 0.0003
476 PYELONEPHRITIS 3 0.0003
477 HALLUCINATION 26 0.0003
478 HYPERSENSITIVITY 64 0.0003
479 SEPTIC SHOCK 15 0.0003
480 ORTHOSTATIC HYPOTENSION 6 0.0003
481 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
482 POST PROCEDURAL HAEMORRHAGE 4 0.0003
483 LOSS OF CONSCIOUSNESS 44 0.0003
484 VASCULITIS 4 0.0003
485 HEAD DISCOMFORT 6 0.0003
486 DEEP VEIN THROMBOSIS 22 0.0003
487 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
488 BACTERAEMIA 4 0.0003
489 GALLBLADDER DISORDER 6 0.0003
490 ACCIDENT 4 0.0003
491 HAEMOLYTIC ANAEMIA 3 0.0003
492 ANAL INCONTINENCE 3 0.0003
493 DIABETIC KETOACIDOSIS 8 0.0003
494 VOMITING 156 0.0003
495 CRYING 12 0.0003
496 THERAPEUTIC RESPONSE DECREASED 20 0.0003
497 BURSITIS 4 0.0003
498 ACCIDENTAL OVERDOSE 12 0.0003
499 INSURANCE ISSUE 5 0.0003
500 RESPIRATORY DEPRESSION 4 0.0003
501 RETINAL DETACHMENT 3 0.0003
502 POOR QUALITY SLEEP 7 0.0003
503 SMALL INTESTINAL OBSTRUCTION 4 0.0003
504 FEELING COLD 9 0.0003
505 EXTRAPYRAMIDAL DISORDER 8 0.0003
506 DELUSION 5 0.0003
507 ILEUS 4 0.0003
508 PRODUCT DISPENSING ERROR 7 0.0003
509 COGNITIVE DISORDER 15 0.0003
510 APPENDICITIS 3 0.0003
511 NERVOUS SYSTEM DISORDER 10 0.0003
512 LACERATION 3 0.0003
513 ARTERIOSCLEROSIS 3 0.0003
514 DERMATITIS ALLERGIC 4 0.0003
515 CYANOSIS 5 0.0003
516 SPINAL DISORDER 3 0.0003
517 URTICARIA 53 0.0003
518 MUSCLE SPASMS 58 0.0003
519 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
520 RED BLOOD CELL COUNT DECREASED 9 0.0003
521 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
522 HYPERKALAEMIA 11 0.0003
523 WEIGHT INCREASED 69 0.0003
524 DIPLOPIA 8 0.0003
525 BLOOD POTASSIUM INCREASED 5 0.0003
526 VITAMIN D DEFICIENCY 3 0.0003
527 PRODUCT USE IN UNAPPROVED INDICATION 76 0.0003
528 PHARYNGEAL SWELLING 3 0.0003
529 METASTASES TO BONE 5 0.0003
530 RESTLESSNESS 11 0.0003
531 SALIVARY HYPERSECRETION 3 0.0003
532 POOR QUALITY DEVICE USED 3 0.0003
533 VISUAL IMPAIRMENT 37 0.0003
534 INTENTIONAL SELF-INJURY 6 0.0003
535 SINUS CONGESTION 4 0.0003
536 PRODUCT TASTE ABNORMAL 4 0.0003
537 SUBARACHNOID HAEMORRHAGE 3 0.0003
538 SLUGGISHNESS 3 0.0003
539 PALLOR 8 0.0003
540 INITIAL INSOMNIA 3 0.0003
541 EMOTIONAL DISORDER 9 0.0003
542 CORONARY ARTERY OCCLUSION 4 0.0003
543 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
544 PARANOIA 5 0.0003
545 POOR VENOUS ACCESS 3 0.0003
546 ABNORMAL DREAMS 8 0.0003
547 EYE DISCHARGE 3 0.0003
548 DIVERTICULITIS 8 0.0003
549 PULMONARY HYPERTENSION 6 0.0003
550 TENDERNESS 3 0.0003
551 RHABDOMYOLYSIS 12 0.0003
552 WEIGHT FLUCTUATION 3 0.0003
553 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
554 DEMENTIA 8 0.0003
555 MASS 4 0.0003
556 RENAL FAILURE 38 0.0003
557 AGITATION 21 0.0003
558 INTENTIONAL PRODUCT USE ISSUE 25 0.0003
559 DYSPHAGIA 27 0.0003
560 DEVICE OCCLUSION 4 0.0003
561 JOINT DISLOCATION 3 0.0003
562 SLEEP DISORDER 20 0.0003
563 DIZZINESS 141 0.0003
564 CYSTITIS 9 0.0003
565 DIALYSIS 4 0.0003
566 JOINT INJURY 6 0.0003
567 BRONCHOSPASM 4 0.0003
568 CEREBRAL HAEMORRHAGE 10 0.0003
569 CELLULITIS 14 0.0003
570 PHARYNGITIS STREPTOCOCCAL 3 0.0003
571 AMNESIA 18 0.0003
572 SWELLING FACE 18 0.0003
573 BIPOLAR DISORDER 3 0.0003
574 BACK INJURY 3 0.0003
575 RESPIRATORY FAILURE 20 0.0003
576 DYSSTASIA 8 0.0003
577 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
578 HOSPITALISATION 42 0.0003
579 PYREXIA 94 0.0003
580 VISUAL ACUITY REDUCED 9 0.0003
581 VIRAL INFECTION 9 0.0003
582 BACTERIAL INFECTION 5 0.0003
583 GASTROINTESTINAL DISORDER 24 0.0003
584 FALL 89 0.0003
585 TYPE 2 DIABETES MELLITUS 9 0.0003
586 SEDATION 7 0.0003
587 INCORRECT DOSE ADMINISTERED BY DEVICE 7 0.0003
588 PANCREATITIS ACUTE 6 0.0003
589 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 54 0.0003
590 ASTHENIA 100 0.0003
591 PHOTOPHOBIA 5 0.0003
592 EYE INFECTION 3 0.0003
593 DEPRESSED MOOD 14 0.0003
594 FRACTURE 5 0.0003
595 BLOOD COUNT ABNORMAL 4 0.0003
596 CARDIO-RESPIRATORY ARREST 11 0.0003
597 EAR INFECTION 7 0.0003
598 HAEMATURIA 9 0.0003
599 FEELING JITTERY 5 0.0003
600 NAUSEA 207 0.0003
601 ACUTE RESPIRATORY FAILURE 5 0.0003
602 LEUKOPENIA 13 0.0003
603 CONDITION AGGRAVATED 79 0.0003
604 CONTUSION 25 0.0003
605 PERICARDIAL EFFUSION 6 0.0003
606 MYALGIA 44 0.0003
607 LUNG INFECTION 4 0.0003
608 RASH MACULAR 9 0.0003
609 BASAL CELL CARCINOMA 4 0.0003
610 BRAIN FOG 4 0.0003
611 MUSCULAR WEAKNESS 29 0.0003
612 PRODUCT USE COMPLAINT 4 0.0003
613 OCULAR HYPERAEMIA 12 0.0003
614 DISABILITY 5 0.0003
615 MYOCLONUS 3 0.0003
616 BLOOD PRESSURE ABNORMAL 5 0.0003
617 PREMATURE DELIVERY 4 0.0003
618 HYPERLIPIDAEMIA 3 0.0003
619 NECK PAIN 14 0.0003
620 MOVEMENT DISORDER 8 0.0002
621 ABDOMINAL DISTENSION 26 0.0002
622 THROMBOSIS 20 0.0002
623 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
624 TREMOR 41 0.0002
625 DYSKINESIA 10 0.0002
626 BRADYCARDIA 13 0.0002
627 BODY TEMPERATURE INCREASED 5 0.0002
628 ALANINE AMINOTRANSFERASE INCREASED 15 0.0002
629 HYPERSOMNIA 7 0.0002
630 MUSCLE SPASTICITY 3 0.0002
631 PRODUCT PREPARATION ERROR 5 0.0002
632 GENERALISED OEDEMA 3 0.0002
633 PHARYNGITIS 3 0.0002
634 DEPRESSION 55 0.0002
635 PARAESTHESIA 38 0.0002
636 TOOTH EXTRACTION 3 0.0002
637 BACK PAIN 56 0.0002
638 DISTURBANCE IN ATTENTION 13 0.0002
639 ABDOMINAL PAIN 56 0.0002
640 LIVER FUNCTION TEST ABNORMAL 7 0.0002
641 PNEUMONIA ASPIRATION 6 0.0002
642 COAGULOPATHY 4 0.0002
643 SKIN DISCOLOURATION 11 0.0002
644 ROAD TRAFFIC ACCIDENT 10 0.0002
645 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 17 0.0002
646 SURGERY 14 0.0002
647 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
648 MOUTH ULCERATION 5 0.0002
649 MUSCLE ATROPHY 3 0.0002
650 INTRAOCULAR PRESSURE INCREASED 3 0.0002
651 SINUSITIS 24 0.0002
652 INFUSION SITE PAIN 3 0.0002
653 HAEMATOMA 6 0.0002
654 HYPERTENSION 49 0.0002
655 DISEASE RECURRENCE 11 0.0002
656 PLATELET COUNT INCREASED 3 0.0002
657 MENTAL DISORDER 10 0.0002
658 DEAFNESS 6 0.0002
659 SUICIDAL IDEATION 21 0.0002
660 JOINT STIFFNESS 6 0.0002
661 INCORRECT PRODUCT STORAGE 3 0.0002
662 PRODUCT QUALITY ISSUE 31 0.0002
663 HYPOXIA 8 0.0002
664 ABDOMINAL DISCOMFORT 38 0.0002
665 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
666 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
667 FEMUR FRACTURE 7 0.0002
668 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
669 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
670 BLOOD PRESSURE DECREASED 15 0.0002
671 MEMORY IMPAIRMENT 31 0.0002
672 ANXIETY 64 0.0002
673 CONSTIPATION 49 0.0002
674 HAIR TEXTURE ABNORMAL 3 0.0002
675 SEPSIS 25 0.0002
676 FATIGUE 174 0.0002
677 DIABETES MELLITUS 17 0.0002
678 OEDEMA PERIPHERAL 27 0.0002
679 CHROMATURIA 5 0.0002
680 LEUKOCYTOSIS 4 0.0002
681 PULMONARY EMBOLISM 21 0.0002
682 BLINDNESS 9 0.0002
683 C-REACTIVE PROTEIN INCREASED 8 0.0002
684 MOOD SWINGS 7 0.0002
685 GAIT DISTURBANCE 42 0.0002
686 UNDERDOSE 16 0.0002
687 METABOLIC ACIDOSIS 7 0.0002
688 MALAISE 96 0.0002
689 OSTEOPOROSIS 9 0.0002
690 INFLUENZA LIKE ILLNESS 18 0.0002
691 PERIPHERAL COLDNESS 3 0.0002
692 RESPIRATORY DISTRESS 6 0.0002
693 IRRITABILITY 13 0.0002
694 DECREASED APPETITE 50 0.0002
695 AGRANULOCYTOSIS 4 0.0002
696 APHONIA 3 0.0002
697 PANCYTOPENIA 12 0.0002
698 THINKING ABNORMAL 4 0.0002
699 HEPATIC FUNCTION ABNORMAL 8 0.0002
700 THERAPY CESSATION 11 0.0002
701 CARPAL TUNNEL SYNDROME 3 0.0002
702 ILLNESS 22 0.0002
703 TUBULOINTERSTITIAL NEPHRITIS 4 0.0002
704 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
705 HOT FLUSH 16 0.0002
706 CARDIAC FAILURE 17 0.0002
707 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
708 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
709 PROTEINURIA 4 0.0002
710 SPEECH DISORDER 11 0.0002
711 EYE PRURITUS 7 0.0002
712 BLOOD GLUCOSE DECREASED 10 0.0002
713 LOWER LIMB FRACTURE 4 0.0002
714 AFFECT LABILITY 2 0.0002
715 GLAUCOMA 4 0.0002
716 DEVICE LEAKAGE 9 0.0002
717 PRODUCT DOSE OMISSION ISSUE 61 0.0002
718 HYPERTHYROIDISM 3 0.0002
719 PRESCRIBED OVERDOSE 4 0.0002
720 HYPOKINESIA 3 0.0002
721 APATHY 3 0.0002
722 DYSPHONIA 12 0.0002
723 MULTIPLE SCLEROSIS RELAPSE 14 0.0002
724 NASAL CONGESTION 12 0.0002
725 ASCITES 6 0.0002
726 KIDNEY INFECTION 4 0.0002
727 ANGIOEDEMA 9 0.0002
728 CARDIOMYOPATHY 3 0.0002
729 LIVER DISORDER 9 0.0002
730 SKIN HAEMORRHAGE 3 0.0002
731 NIGHTMARE 7 0.0002
732 SINUS DISORDER 4 0.0002
733 HAEMATOCRIT DECREASED 4 0.0002
734 BLADDER DISORDER 2 0.0002
735 PULMONARY OEDEMA 9 0.0002
736 UPPER LIMB FRACTURE 4 0.0002
737 DRY EYE 10 0.0002
738 DRUG INEFFECTIVE 263 0.0002
739 ABDOMINAL PAIN UPPER 41 0.0002
740 ECONOMIC PROBLEM 3 0.0002
741 ABDOMINAL PAIN LOWER 5 0.0002
742 OSTEOPENIA 3 0.0002
743 PNEUMONIA 64 0.0002
744 DEVICE BREAKAGE 8 0.0002
745 DEVICE FAILURE 3 0.0002
746 BALANCE DISORDER 17 0.0002
747 CHILLS 23 0.0002
748 HIP ARTHROPLASTY 3 0.0002
749 INSOMNIA 52 0.0002
750 DEVICE RELATED INFECTION 3 0.0002
751 MUSCULOSKELETAL CHEST PAIN 3 0.0002
752 TENDONITIS 3 0.0002
753 HYPOAESTHESIA 29 0.0002
754 BLOOD CHOLESTEROL INCREASED 9 0.0002
755 ACUTE MYELOID LEUKAEMIA 3 0.0002
756 THERAPY PARTIAL RESPONDER 3 0.0002
757 HYPERGLYCAEMIA 7 0.0002
758 NERVOUSNESS 10 0.0002
759 DRUG-INDUCED LIVER INJURY 6 0.0002
760 MATERNAL EXPOSURE DURING PREGNANCY 17 0.0002
761 ARRHYTHMIA 9 0.0002
762 BRONCHITIS 14 0.0002
763 HALLUCINATION, AUDITORY 3 0.0002
764 ULCER 3 0.0002
765 INFLUENZA 21 0.0002
766 PERIPHERAL SWELLING 29 0.0002
767 EYE SWELLING 7 0.0002
768 EATING DISORDER 4 0.0002
769 PAIN 115 0.0002
770 PRODUCT USE ISSUE 35 0.0002
771 JAUNDICE 5 0.0002
772 OVERDOSE 40 0.0002
773 BLOOD BILIRUBIN INCREASED 5 0.0002
774 THROAT TIGHTNESS 5 0.0002
775 VAGINAL HAEMORRHAGE 8 0.0002
776 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
777 CEREBROVASCULAR ACCIDENT 31 0.0002
778 CHOLELITHIASIS 6 0.0002
779 THERAPY INTERRUPTED 13 0.0002
780 STAPHYLOCOCCAL INFECTION 6 0.0002
781 EMOTIONAL DISTRESS 22 0.0002
782 CARDIAC ARREST 15 0.0002
783 VENTRICULAR TACHYCARDIA 3 0.0002
784 DIARRHOEA 117 0.0002
785 VERTIGO 11 0.0002
786 LIP SWELLING 6 0.0002
787 SKIN DISORDER 6 0.0002
788 NASOPHARYNGITIS 33 0.0002
789 DRUG DOSE OMISSION BY DEVICE 14 0.0002
790 GLOSSODYNIA 4 0.0002
791 HYPERHIDROSIS 23 0.0002
792 DEVICE ISSUE 16 0.0002
793 CHEST PAIN 33 0.0002
794 EYE PAIN 10 0.0002
795 HEART RATE IRREGULAR 4 0.0002
796 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
797 HAEMOGLOBIN DECREASED 18 0.0002
798 ERYTHEMA 36 0.0002
799 ATRIAL FIBRILLATION 17 0.0002
800 TINNITUS 8 0.0002
801 OFF LABEL USE 152 0.0002
802 NEUTROPHIL COUNT DECREASED 7 0.0002
803 FEELING ABNORMAL 41 0.0002
804 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
805 PANCREATITIS 9 0.0002
806 COLD SWEAT 3 0.0002
807 ACUTE KIDNEY INJURY 26 0.0002
808 LYMPHOCYTE COUNT DECREASED 3 0.0002
809 RASH ERYTHEMATOUS 8 0.0002
810 BLOOD PRESSURE FLUCTUATION 4 0.0002
811 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
812 TOXICITY TO VARIOUS AGENTS 28 0.0002
813 HEPATIC FAILURE 5 0.0002
814 TOOTHACHE 3 0.0002
815 LOCALISED INFECTION 4 0.0002
816 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
817 PELVIC PAIN 3 0.0002
818 CORONARY ARTERY DISEASE 5 0.0002
819 PANIC ATTACK 6 0.0002
820 PRESYNCOPE 4 0.0002
821 RECTAL HAEMORRHAGE 7 0.0002
822 ANAEMIA 31 0.0002
823 INCORRECT DOSE ADMINISTERED 37 0.0002
824 OROPHARYNGEAL PAIN 15 0.0002
825 ABNORMAL WEIGHT GAIN 2 0.0002
826 ARTHRALGIA 67 0.0002
827 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
828 FOETAL EXPOSURE DURING PREGNANCY 13 0.0002
829 DYSPNOEA EXERTIONAL 6 0.0002
830 COUGH 44 0.0002
831 BURNING SENSATION 11 0.0002
832 COLITIS ULCERATIVE 7 0.0002
833 HYPOTHYROIDISM 5 0.0002
834 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
835 DYSPNOEA 88 0.0002
836 DRUG INTOLERANCE 15 0.0002
837 NIGHT SWEATS 5 0.0002
838 RHINORRHOEA 10 0.0002
839 EAR PAIN 3 0.0002
840 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
841 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
842 HAEMORRHOIDS 3 0.0002
843 CHOKING 3 0.0002
844 PRODUCT DOSE OMISSION 10 0.0002
845 BLOOD CREATININE INCREASED 10 0.0002
846 MOBILITY DECREASED 11 0.0002
847 APPLICATION SITE ERYTHEMA 4 0.0002
848 IMPAIRED HEALING 5 0.0002
849 EYE DISORDER 5 0.0002
850 ADVERSE EVENT 14 0.0002
851 ANKYLOSING SPONDYLITIS 2 0.0002
852 ASTHMA 17 0.0002
853 PRESCRIBED UNDERDOSE 3 0.0002
854 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
855 PREGNANCY 3 0.0001
856 FULL BLOOD COUNT DECREASED 3 0.0001
857 FEEDING DISORDER 3 0.0001
858 WEIGHT DECREASED 41 0.0001
859 PRODUCTIVE COUGH 7 0.0001
860 CHEST DISCOMFORT 15 0.0001
861 MULTIPLE SCLEROSIS 7 0.0001
862 GASTRIC DISORDER 5 0.0001
863 PROCEDURAL PAIN 4 0.0001
864 HAEMOPTYSIS 4 0.0001
865 DERMATITIS 3 0.0001
866 DRY SKIN 19 0.0001
867 DEVICE MALFUNCTION 10 0.0001
868 DYSPEPSIA 14 0.0001
869 LYMPHADENOPATHY 5 0.0001
870 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
871 PLATELET COUNT DECREASED 15 0.0001
872 INTENTIONAL DOSE OMISSION 4 0.0001
873 SKIN CANCER 3 0.0001
874 HERPES ZOSTER 8 0.0001
875 DRUG DOSE OMISSION 23 0.0001
876 SWELLING 13 0.0001
877 VISION BLURRED 19 0.0001
878 INFECTION 20 0.0001
879 ANOSMIA 2 0.0001
880 PRODUCT PRESCRIBING ISSUE 3 0.0001
881 ALOPECIA 27 0.0001
882 MELAENA 3 0.0001
883 PAIN IN EXTREMITY 40 0.0001
884 INFLAMMATION 7 0.0001
885 LABORATORY TEST ABNORMAL 4 0.0001
886 STEVENS-JOHNSON SYNDROME 3 0.0001
887 TRANSAMINASES INCREASED 3 0.0001
888 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
889 THROMBOCYTOPENIA 15 0.0001
890 ORAL PAIN 3 0.0001
891 PREMATURE BABY 4 0.0001
892 NEUTROPENIA 18 0.0001
893 HEPATIC ENZYME INCREASED 9 0.0001
894 DRUG ADMINISTRATION ERROR 4 0.0001
895 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
896 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
897 CARDIAC DISORDER 12 0.0001
898 NEUROPATHY PERIPHERAL 12 0.0001
899 MUSCULOSKELETAL STIFFNESS 11 0.0001
900 COVID-19 22 0.0001
901 INJECTION SITE BRUISING 10 0.0001
902 ABORTION SPONTANEOUS 5 0.0001
903 EXTRA DOSE ADMINISTERED 5 0.0001
904 FIBROMYALGIA 3 0.0001
905 BACK DISORDER 2 0.0001
906 LIVER INJURY 3 0.0001
907 EXPIRED PRODUCT ADMINISTERED 4 0.0001
908 FUNGAL INFECTION 4 0.0001
909 RASH 52 0.0001
910 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
911 ACNE 9 0.0001
912 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
913 HAEMATEMESIS 3 0.0001
914 DRUG RESISTANCE 3 0.0001
915 BLOOD GLUCOSE INCREASED 22 0.0001
916 SKIN ULCER 3 0.0001
917 NO ADVERSE EVENT 21 0.0001
918 RASH GENERALISED 3 0.0001
919 STOMATITIS 7 0.0001
920 DEVICE USE ERROR 4 0.0001
921 ECZEMA 6 0.0001
922 MUCOSAL INFLAMMATION 3 0.0001
923 PRURITUS 44 0.0001
924 ARTHRITIS 9 0.0001
925 HEART RATE DECREASED 4 0.0001
926 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 8 0.0001
927 CARDIAC FAILURE CONGESTIVE 9 0.0001
928 THROAT IRRITATION 5 0.0001
929 MYELOSUPPRESSION 4 0.0001
930 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
931 HAEMATOCHEZIA 6 0.0001
932 DYSGEUSIA 8 0.0001
933 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
934 INTESTINAL OBSTRUCTION 4 0.0001
935 PAIN IN JAW 3 0.0001
936 ANGINA PECTORIS 3 0.0001
937 MYOCARDIAL INFARCTION 18 0.0001
938 DISEASE PROGRESSION 12 0.0001
939 CATARACT 6 0.0001
940 LACRIMATION INCREASED 3 0.0001
941 SUICIDE ATTEMPT 6 0.0001
942 ILL-DEFINED DISORDER 6 0.0001
943 INJECTION SITE RASH 3 0.0001
944 GYNAECOMASTIA 3 0.0001
945 LIMB DISCOMFORT 3 0.0001
946 MUSCULOSKELETAL PAIN 5 0.0001
947 DERMATITIS ATOPIC 5 0.0001
948 INTENTIONAL OVERDOSE 6 0.0001
949 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
950 NEOPLASM MALIGNANT 6 0.0001
951 GAIT INABILITY 3 0.0001
952 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 16 0.0001
953 INJECTION SITE PAIN 27 0.0001
954 INJECTION SITE REACTION 6 0.0001
955 EYE IRRITATION 5 0.0001
956 BONE PAIN 5 0.0001
957 WHEEZING 5 0.0001
958 INCORRECT ROUTE OF DRUG ADMINISTRATION 3 0.0001
959 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
960 SKIN EXFOLIATION 7 0.0001
961 DRUG EFFECT INCOMPLETE 3 0.0001
962 DEATH 70 0.0001
963 AGEUSIA 2 0.0001
964 INTENTIONAL PRODUCT MISUSE 7 0.0001
965 COLITIS 3 0.0001
966 DRUG ABUSE 6 0.0001
967 ARTHROPATHY 4 0.0001
968 BLISTER 4 0.0001
969 OXYGEN SATURATION DECREASED 4 0.0001
970 HYPOACUSIS 3 0.0001
971 PSORIASIS 9 0.0001
972 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
973 ADVERSE DRUG REACTION 6 0.0001
974 THERAPY NON-RESPONDER 3 0.0001
975 JOINT SWELLING 8 0.0001
976 DISCOMFORT 4 0.0001
977 RENAL DISORDER 3 0.0001
978 BREAST CANCER 6 0.0001
979 PALPITATIONS 7 0.0001
980 INJECTION SITE PRURITUS 4 0.0001
981 ANGER 2 0.0001
982 DRUG WITHDRAWAL SYNDROME 5 0.0001
983 CHRONIC KIDNEY DISEASE 4 0.0001
984 INJECTION SITE HAEMORRHAGE 4 0.0001
985 DRUG DEPENDENCE 8 0.0000
986 PROSTATE CANCER 4 0.0000
987 FEBRILE NEUTROPENIA 3 0.0000
988 INJECTION SITE SWELLING 3 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
990 TREATMENT FAILURE 3 0.0000
991 COMPLETED SUICIDE 3 0.0000
992 INJECTION SITE ERYTHEMA 4 0.0000